Find the resources suppliers need here
Supplier product/process change notification
All suppliers are required to notify and receive written approval from BD prior to making any changes to the design or manufacture of products we purchase from you. Review the training materials for our Product/Process change notification (PCN). After reviewing the training materials, you may
If you have any questions, contact BD at GMB-CFN-SupplierPCN@carefusion.com.
BD conflict minerals policy
BD is dedicated to complying with Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 relating to the use of "conflict minerals." BD is committed to working with suppliers that responsibly source the materials and components used in the manufacture of our products. We recognize that compliance with these obligations requires time and effort from our supply chain; however, we expect that suppliers will take reasonable, good faith steps in helping us achieve our compliance obligations.
Learn more about our commitment to this Act
Unique device identifier compliance
On September 24, 2013, the U.S. Food and Drug Administration (FDA) released a final rule requiring that most medical devices distributed in the United States carry a unique device identifier (UDI). The UDI system facilitates medical device identification, traceability and tracking through distribution and use. Due to this new regulation, BD is transitioning to the new UDI regulation to comply with the FDA deadline dates.
Learn more about our commitment to this ruling